Welcome to our dedicated page for PERIMETER MED IMAGING AI news (Ticker: PYNKF), a resource for investors and traders seeking the latest updates and insights on PERIMETER MED IMAGING AI stock.
Perimeter Medical Imaging AI, Inc. (PYNKF) is a commercial-stage medical technology company focused on transforming cancer surgery. Headquartered in Toronto, Canada, and Dallas, Texas, the company provides ultra-high-resolution, real-time, advanced imaging tools to address critical medical needs. With FDA-cleared Perimeter S-Series OCT system for cellular-level visualization and investigational Perimeter B-Series OCT with ImgAssist AI, Perimeter is at the forefront of utilizing artificial intelligence to enhance surgical outcomes and patient care.
Rhea-AI Summary
Perimeter Medical Imaging AI, Inc. (PINK) announced a follow-on commercial placement of its flagship Perimeter S-Series OCT system at a new hospital site within one of the largest healthcare networks in North Texas, part of a major national healthcare system. The S-Series OCT provides cross-sectional, real-time margin visualization of excised tissue specimens in the operating room at 10 times higher image resolution than X-ray and ultrasound, and 100 times greater image resolution than MRI.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20%
Tags
-
Rhea-AI Summary
Perimeter Medical Imaging AI, Inc. (PINK) to Participate in Investor Webinar Discussing AI in Cancer Surgery with Dr. Amelia Tower
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.33%
Tags
-
Rhea-AI Summary
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) announced the appointment of Adrian Mendes to its Board of Directors. The company reported financial results for Q3 2023, highlighting advancements in a grant funding program, positive interactions with the FDA, initiation of additional clinical trial sites, and the appointment of Adam Hodges as Vice President, Sales and Marketing. The CEO, Adrian Mendes, expressed satisfaction with the progress made, particularly in the development of next-gen AI tech for clinical trials, and the company's shortlisting for a grant funding program sponsored by ARPA-H under the Biden Cancer Moonshot Initiative.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5%
Tags
Rhea-AI Summary
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) will report its Q3 2023 financial and operating results on November 14, 2023, after the U.S. financial markets close. The conference call/webcast, featuring CEO Adrian Mendes, will provide insights into the company's performance and future prospects.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.23%
Tags
-
Rhea-AI Summary
Perimeter Medical Imaging AI, Inc. has announced the initiation of an additional clinical trial site at the University of Washington / Fred Hutch Cancer Center in Seattle, WA. The trial is evaluating the Perimeter B-Series OCT combined with its proprietary ImgAssist AI software for breast conservation surgeries. The company aims to improve patient outcomes and reduce healthcare costs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.89%
Tags
-
Rhea-AI Summary
Perimeter Medical Imaging AI will host an investor webcast on October 25, 2023, to provide an overview of key areas of the company's business.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.22%
Tags
Rhea-AI Summary
Perimeter Medical Imaging AI announces patient randomization underway at clinical trial site at Mayo Clinic in Florida
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Perimeter Medical Imaging AI, Inc. shortlisted in grant funding process for Precision Surgical Interventions (PSI) Program.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Perimeter Medical Imaging AI grants 3,523,408 stock options and amends vesting schedules for certain employees.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary
Perimeter Medical Imaging AI, Inc. appoints Adam Hodges as VP of Sales and Marketing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.81%
Tags
FAQ
What is the current stock price of PERIMETER MED IMAGING AI (PYNKF)?
The current stock price of PERIMETER MED IMAGING AI (PYNKF) is $0.4419 as of November 22, 2024.
What is the market cap of PERIMETER MED IMAGING AI (PYNKF)?
The market cap of PERIMETER MED IMAGING AI (PYNKF) is approximately 38.3M.
What is Perimeter Medical Imaging AI, Inc. focused on?
Perimeter Medical Imaging AI is dedicated to transforming cancer surgery through advanced imaging technology and artificial intelligence-driven solutions.
Where is Perimeter Medical Imaging AI, Inc. headquartered?
Perimeter's headquarters are located in Toronto, Canada, and Dallas, Texas.
What products does Perimeter Medical Imaging AI, Inc. offer?
The company provides the FDA-cleared Perimeter S-Series OCT system and the investigational Perimeter B-Series OCT with ImgAssist AI for real-time visualization and AI-driven support during surgeries.
What sets Perimeter Medical Imaging AI, Inc. apart in the medical technology industry?
Perimeter's focus on ultra-high-resolution imaging tools, commitment to addressing unmet medical needs, and innovative use of AI distinguish it in the field.
How is Perimeter Medical Imaging AI, Inc. contributing to cancer surgery advancements?
By developing cutting-edge technology like the Perimeter S-Series OCT and B-Series OCT with ImgAssist AI, Perimeter is revolutionizing cancer surgery practices.
What is the significance of Perimeter Medical Imaging AI, Inc.'s ticker symbol 'PINK'?
The company's ticker symbol 'PINK' is a nod to Breast Cancer Awareness Month, highlighting its dedication to enhancing breast cancer diagnosis and treatment.
Where can I find more information about Perimeter Medical Imaging AI, Inc.'s disclosures and products?
For additional details on Perimeter's offerings and disclosures, visit their website at perimetermed.com/disclosures.
What recent achievements has Perimeter Medical Imaging AI, Inc. showcased?
Perimeter's recent milestones include successful product placements, significant progress in clinical trials, and engagement with industry experts to drive innovation.
How can investors stay informed about Perimeter Medical Imaging AI, Inc.'s updates and performance?
Investors can access the latest news, financial results, and corporate updates from Perimeter by following their press releases, financial filings, and investor relations communications.
What partnerships or collaborations has Perimeter Medical Imaging AI, Inc. established?
Perimeter collaborates with leading healthcare networks, regulatory bodies, and industry experts to drive technological advancements and enhance cancer surgery practices.
PERIMETER MED IMAGING AI